Pfizer
at Investor's Business Daily - Tue Sep 23, 5:45PM CDT
Pfizer (PFE) is exploring a bid for Actavis (ACT) and has approached officials at the generic-drug firm, but formal talks haven't started, according to Bloomberg sources. Pfizer shares fell 0.4% to 30.05. Actavis rose 2.2% to 240.85.
Stocks Finish Lower Among Takeover Rumors
at Investor's Business Daily - Tue Sep 23, 5:06PM CDT
Stocks finished the day down moderately, with the Nasdaq and the S&P 500 lower for the third straight day. Volume was running lighter than the previous day, according to preliminary figures. The Nasdaq was down 0.4%; the S&P 500 fell 0.6% and the Dow...
Most active New York Stock Exchange-traded stocks
AP - Tue Sep 23, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Tue Sep 23, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
Stock Market Today: U.S. Stocks in 3-Day Losing Streak as U.S. Strikes Syria
at The Street - Tue Sep 23, 3:47PM CDT
The U.S. stocks fell for a third day as U.S. fighter jets attack the Islamic State militia in Syria.
Stocks Fall To Session Lows; Vipshop Bucks The Trend
at Investor's Business Daily - Tue Sep 23, 2:00PM CDT
Selling picked up the pace in the major averages in late-afternoon trading Tuesday. The Dow Jones industrial average fell 0.6%; the S&P 500 gave up 0.4% and the Nasdaq lost 0.3%. NYSE and Nasdaq volume was tracking about 5% to 10% lower than Monday's...
Why Actavis (ACT) Stock Is Higher Today
at The Street - Tue Sep 23, 1:36PM CDT
Pfizer( PFE) reportedly approached the company to express its interest in an acquisition, as Pfizer continues to explore ways to cut its tax rate and gain a new product pipeline.
Midday Glance: Pharmaceuticals companies
AP - Tue Sep 23, 12:20PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
US clampdown on tax maneuver leaves its mark
By The Associated Press - AP - Tue Sep 23, 12:10PM CDT
NEW YORK (AP) — A handful of big companies pursuing overseas mergers to lower their tax bills came under pressure Tuesday after the U.S. unveiled rules to discourage them.
Early Glance: Pharmaceuticals companies
AP - Tue Sep 23, 9:29AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Why Pfizer (PFE) Stock Is Down Today
at The Street - Tue Sep 23, 9:19AM CDT
Shares of Pfizer (PFE) and AstraZeneca (AZN) fell Tuesday after the U.S. Treasury Department and the IRS announced a plan to decrease inversion tax benefits.
Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts
Business Wire - Tue Sep 23, 9:00AM CDT
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, October 28, 2014. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's Third Quarter 2014 Performance Report, to be issued that morning.
Stock Market Today: Traders Gear Up for Volatility Spike
at The Street - Tue Sep 23, 8:15AM CDT
U.S. stock futures are pointing to another weak day on Wall Street Tuesday.
Kim Cattrall Encourages Women to Embrace Menopause with Style
Business Wire - Tue Sep 23, 7:01AM CDT
Every day, an estimated 6,000 women in the United States reach menopause.(1) To inspire this growing population of women and to share her story, Golden Globe(R) winning actress Kim Cattrall has teamed up with Pfizer Inc. (NYSE
European Stocks Tumble Amid U.S. Clampdown on Tax Inversions
at The Street - Tue Sep 23, 5:08AM CDT
European stock indices plunge on Tuesday amid profit warnings from high-profile companies and fears that a U.S. clampdown will stem the tide of American deal-making in Europe.
Pfizer (PFE) Approaches New Downside Target of $29.92
Comtex SmarTrend(R) - Mon Sep 22, 10:40AM CDT
Shares of Pfizer (NYSE
Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo
PR Newswire - Mon Sep 22, 8:05AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), AbbVie Inc. (NYSE: ABBV), Pfizer Inc. (NYSE: PFE), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL) and Endo International plc (NASDAQ: ENDP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6643-100free.
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations
Business Wire - Mon Sep 22, 7:01AM CDT
Circle Pharma, Inc., a newly created, early-stage biotechnology company, today announced that it has received seed funding from Pfizer Inc. and QB3's seed-stage venture fund, Mission Bay Capital, LLC, and has initiated two collaborations with Pfizer to develop cell permeable macrocyclic peptide therapeutics.
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers
Business Wire - Mon Sep 22, 7:00AM CDT
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced charitable donations totaling more than $1 million to be granted between 2014 and 2016 to seven nonprofit organizations that support patients with cardiovascular disease. The donations will fund the independent development of innovative educational materials about stroke risk reduction in patients with nonvalvular atrial fibrillation (NVAF). The materials, accessible to both patients and caregivers, will address disease awareness, identification of signs and symptoms, access to care, appropriate treatment options, shared decision making and medication adherence. National Stroke Association, Heart Rhythm Society, American College of Physicians, American Heart Association Founders Affiliate, Regents of the University of Michigan/Society for Vascular Medicine, WomenHeart and American College of Emergency Physicians will each receive a charitable donation to support their independent educational initiatives.